Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis
- First Posted Date
- 2014-04-01
- Last Posted Date
- 2019-02-18
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 220
- Registration Number
- NCT02100813
- Locations
- 🇺🇸
Gwinnett Clinical Research Center, Inc., Snellville, Georgia, United States
Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
- First Posted Date
- 2014-03-18
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 840
- Registration Number
- NCT02090465
- Locations
- 🇩🇪
Universitätsklinikum Heidelberg/Klinische Sozialmedizin, Heidelberg, Germany
An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects
- First Posted Date
- 2014-01-16
- Last Posted Date
- 2018-11-06
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 125
- Registration Number
- NCT02038569
- Locations
- 🇩🇪
Charite Berlin, Berlin, Germany
🇺🇸Rady's Children Hospital, San Diego, California, United States
🇺🇸Clinical Research Center, Morsani Center for Advanced Healthcare, Tampa, Florida, United States
Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
- First Posted Date
- 2013-12-03
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 266
- Registration Number
- NCT01998984
- Locations
- 🇺🇸
Long Island Skin Cancer and Dermatologic Surgery, Smithtown, New York, United States
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life
- Conditions
- First Posted Date
- 2013-11-13
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 147
- Registration Number
- NCT01982552
- Locations
- 🇺🇸
Grekin Skin Institute, Warren, Michigan, United States
🇺🇸Center for Dermatology Clinical Research, Fremont, California, United States
🇺🇸Psoriasis Treatment Center of Central NJ, East Windsor, New Jersey, United States
Topical Aprepitant in Prurigo Patients
- First Posted Date
- 2013-10-16
- Last Posted Date
- 2021-07-16
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 20
- Registration Number
- NCT01963793
- Locations
- 🇩🇪
Allergie-Zentrum-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany
A Vasoconstriction Study With LEO 90100
- First Posted Date
- 2013-09-19
- Last Posted Date
- 2019-03-29
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 35
- Registration Number
- NCT01946386
- Locations
- 🇫🇷
CPCAD, Centre de Pharmacologie Clinique Appliquée à la Dermatologie, Nice, France
Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100
- Conditions
- Interventions
- First Posted Date
- 2013-09-05
- Last Posted Date
- 2019-03-29
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 224
- Registration Number
- NCT01935869
- Locations
- 🇫🇷
CPCAD, Centre de Pharmacologie Clinique Appliquée à la Dermatologie, Hôpital de l'Archet 2, Nice Cedex 3, France
Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
- Conditions
- Interventions
- First Posted Date
- 2013-08-21
- Last Posted Date
- 2020-08-21
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 485
- Registration Number
- NCT01926496
- Locations
- 🇬🇧
Ninewells Hospital, Dundee, Angus, United Kingdom
🇬🇧Scunthorpe General Hospital, Scunthorpe, Lincolnshire, United Kingdom
🇬🇧East Surrey Hospital, Redhill, Surrey, United Kingdom
A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
- Conditions
- Interventions
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2019-02-27
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 320
- Registration Number
- NCT01922050
- Locations
- 🇺🇸
Torrance Clinical Research Institute Inc., Lomita, California, United States
🇺🇸Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc., San Diego, California, United States
🇺🇸Omni Dermatology, Phoenix, Arizona, United States